Current Opinion in Lipidology was launched in 1990. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of lipidology is divided into six sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editor for this issue.
Paul N. Durrington
Dr Paul N. Durrington MD FRCP FRCPath FAHA FMedSci retired from his substantive post as Professor of Medicine at the University of Manchester in 2009 and retired as Consultant Physician at Manchester Royal Infirmary, UK in 2012. Since 2009 he has continued to work in the Cardiovascular Research Group of the University of Manchester as Honorary Professor of Medicine. He graduated in physiology and medicine at the University of Bristol and trained in general (internal) medicine, diabetes mellitus and metabolic disorders. From 1979–80, he worked at the University of California, San Diego, USA, as a travelling fellow of the British Heart Foundation and American Heart Association. His research interests centre on disorders of lipoprotein metabolism, atherogenic modification of lipoproteins, insulin resistance and diabetes and the translation of clinical trial evidence into practice. In 2001 he was elected to the Fellowship of the Academy of Medical Sciences for his work on diabetic dyslipidaemia and on HDL metabolism. He was Chairman of the British Hyperlipidaemia Association (1992–1995), a member of the British Heart Foundation Project Grants Committee (1997–2000), Director of Research and Development at the Central Manchester Healthcare Trust (1997–2001) and from 2008 to 2012 he led the Greater Manchester Vascular Research Network. He has been a member of the European Cardiac Society Task Force on Dyslipidaemia (2009–2015) and a consultant to the National Institute of Health and Care Excellence (NICE). Currently, he chairs the Steering Committee of a National Institute of Health Research funded project to evaluate protocols for identifying and managing patients with familial hypercholesterolaemia. He is author of over 400 original papers and other publications including Hyperlipidaemia: Diagnosis and Management 3rd Edition (2007, London: Hodder Arnold).Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.